‘The reading of the will’: making inheritance law visual
International Journal of Law in Context · 24.04.2026 · 1-27
DOI: 10.1017/s1744552326100494 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Law in Context, online erschienen am 24.04.2026. Verfasst von Daniel Monk. Die Arbeit nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Wills have lent themselves to more performative possibilities than any other legal document. They have been engraved, painted, written about and sung. Yet within legal scholarship these representations have been overlooked. Interpreting the Reading of the Will widely, this article demonstrates the tenacity of the will on artistic imagination and, at the same time, its starkly shifting functions and audiences. Adopting a chronological approach, it examines church monuments from the sixteenth century, nineteenth-century ‘realist’ paintings and novels, twentieth-century crime fiction, comic operas and figurative domestic porcelain, and more recent gritty and glamorous TV soaps and contemporary performance art. Aided by scholarship across a wide range of disciplines, it argues that this diverse work mirrors and illuminates historical, political and sociological debates about the public and private nature of inheritance. In a hyper-visual world, it makes a case for taking artistic endeavours seriously within legal scholarship and pedagogy.
Zitieren
APA
Monk, D. (2026). ‘The reading of the will’: making inheritance law visual. International Journal of Law in Context, 1-27. https://doi.org/10.1017/s1744552326100494
Vancouver
Monk D. ‘The reading of the will’: making inheritance law visual. International Journal of Law in Context. 2026:1-27. doi:10.1017/s1744552326100494
BibTeX
@article{Monk2026,
author = {Monk, Daniel},
title = {‘The reading of the will’: making inheritance law visual},
journal = {International Journal of Law in Context},
year = {2026},
pages = {1--27},
doi = {10.1017/s1744552326100494}
}
EUVIMED